Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.810
+0.220 (6.13%)
At close: Aug 24, 2026, 4:00 PM EDT
3.750
-0.060 (-1.57%)
After-hours: Aug 24, 2026, 6:56 PM EDT

Xenetic Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.262.982.52.541.711.16
Revenue Growth
33.30%19.04%-1.56%48.80%47.06%165.64%
Gross Profit
3.262.982.52.541.711.16
Selling, General & Admin
3.162.753.423.563.653.74
Research & Development
2.743.073.293.494.773.16
Operating Expenses
5.95.816.77.068.426.91
Operating Income
-2.64-2.83-4.2-4.52-6.72-5.75
Interest & Investment Income
0.160.150.250.360.170.1
Other Non Operating Income (Expenses)
00.01-0.010.03-00
EBT Excluding Unusual Items
-2.48-2.68-3.96-4.13-6.55-5.65
Pretax Income
-2.48-2.68-3.96-4.13-6.55-5.65
Net Income
-2.48-2.68-3.96-4.13-6.55-5.65
Net Income to Common
-2.48-2.68-3.96-4.13-6.55-5.65
Net Income Growth
------
Shares Outstanding (Basic)
222211
Shares Outstanding (Diluted)
222211
Shares Change
34.68%10.40%0.86%7.44%38.38%60.81%
EPS (Basic)
-1.19-1.58-2.57-2.71-4.61-5.49
EPS (Diluted)
-1.19-1.58-2.57-2.71-4.61-5.49
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2.31-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Per Share
-1.11-1.34-1.83-2.69-3.27-4.61
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-81.01%-95.23%-168.16%-177.78%-393.57%-495.12%
Profit Margin
-75.91%-90.07%-158.39%-162.78%-383.87%-486.36%
Free Cash Flow Margin
-70.93%-76.83%-112.69%-161.98%-272.23%-408.21%
EBITDA
------5.75
D&A For EBITDA
-----0
EBIT
-2.64-2.83-4.2-4.52-6.72-5.75
EBIT Margin
-81.01%-95.23%-168.16%-177.78%--
Revenue as Reported
3.262.982.52.541.711.16
SEC Filings: 10-K · 10-Q